Catalyst Pharmaceuticals (CPRX) Tax Rate (2019 - 2026)

Catalyst Pharmaceuticals has reported Tax Rate for 8 years, with the latest figure at 24.33% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate rose 392.0% year-over-year to 24.33%; the trailing twelve-month figure through Mar 2026 stood at 27.63% (up 33.0% YoY), and the FY2025 full-year result was 26.79%, down 180.0% from the prior year.
• Tax Rate for Q1 2026 stood at 24.33%, down from 36.12% in the prior quarter.
• The five-year high for Tax Rate was 63.52% in Q4 2023, with the low at 3.77% in Q4 2022.
• Historically, Tax Rate has averaged 24.75% across 5 years, with a median of 23.46% in 2022.
• Annual changes were most pronounced in 2022 — Tax Rate slumped 3112 bps — and 2023, when it soared 6729 bps.
• Catalyst Pharmaceuticals' Tax Rate stood at 3.77% in 2022, then jumped by 1784 bps to 63.52% in 2023, then sank by 41 bps to 37.34% in 2024, then declined by 3 bps to 36.12% in 2025, then plunged by 33 bps to 24.33% in 2026.
• The last three Tax Rate figures came in at 24.33% (Q1 2026), 36.12% (Q4 2025), and 25.69% (Q3 2025), per Business Quant data.